Book Value per Share: Monte Rosa Tx (GLUE)

Graphic logo of Monte Rosa Therapeutics, Inc. (GLUE)

Monte Rosa Therapeutics (GLUE) is creating an innovative "molecular glue" environment to eliminate previously undruggable pathogenic proteins. The company relies on an extensive network of research centers, which reduces the likelihood of trial failures and supports project margins. The current figure stands at 5.74, while this asset value chart complements data on laboratory upgrades and the planned capacity utilization for biomaterial synthesis.

GLUE: Monte Rosa Tx Net Asset Value per Share 07/04/2022 - 10/26/2026

monterosatx.com - analytical breakdowns and key metrics (GLUE)

- price and consensus price forecast:
Stock Quotes Monte Rosa Tx|GLUE - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Monte Rosa Therapeutics, Inc.|GLUE - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share Monte Rosa Therapeutics|GLUE - Total Stockholders' Equity|Market Value to Book Value Ratio monterosatx.com|GLUE - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Monte Rosa Therapeutics|GLUE - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Monte Rosa Therapeutics, Inc.|GLUE - Company Cumulative Debt|Debt to Book Capitalization Ratio Monte Rosa Therapeutics, Inc.
Fundamental company valuation:GLUE - Monte Rosa Tx
Flagship merchandise of Monte Rosa Therapeutics, Inc.

The stability of Monte Rosa Therapeutics (GLUE) is underpinned by the diversification of its molecular glue platform for oncology therapy, which mitigates specific scientific risks. The bvps trend on GURU.Markets reflects the net asset value per share, demonstrating the actual capital supporting the issuer's market value and enabling the determination of a fair business valuation.

Competitor analysis for Monte Rosa Therapeutics

Genmab US - Accounting Value per Share|EXEL - Book Value per Share|Book Value per Share NUVL|KYMR (kymeratx.com) - Net Asset Value per Share|Net Assets per Single Share IDYA (IDEAYA Biosciences, Inc.)|Net Asset Value per Share ELVN|Net Assets per Single Share ORIC Pharma ORIC|Equity per Share Relay Corp (RLAY)|Nurix Therapeutics - Book Value per Share|tyra.bio - Accounting Value per Share|VSTM (Verastem) - Net Assets per Single Share|CGEM: Net Asset Value per Share|Immuneering Inc. (IMRX) - Net Assets per Single Share|CCCC (C4 Therapeutics Corp) - Net Assets per Single Share|Net Assets per Single Share BDTX (Black Diamond)|Net Asset Value per Share reparerx.com|PMVP: Book Value per Share|Book Value of One Share karyopharm.com KPTI|PPCB: Accounting Value per Share|BGMS - Net Asset Value per Share|Accounting Value per Share Aadi Bio (AADI)|Aileron Therapeutics (ALRN) - Accounting Value of a Share|BPMC - Accounting Value per Share|GlycoMimetics (GLYC) - Book Price of a Share|SWTX (SpringWorks) - Book Value per Share